FdaApplication
ANDA 205981
Identifiers
- fda_app_no: ANDA205981
Properties
| Property | Value |
|---|---|
| applicant_name | MYLAN PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2023-07-31 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE | 1GM;EQ 2.5MG BASE | TABLET, EXTENDED RELEASE;ORAL |
| SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE | 500MG;EQ 5MG BASE | TABLET, EXTENDED RELEASE;ORAL |
| SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE | 1GM;EQ 5MG BASE | TABLET, EXTENDED RELEASE;ORAL |
3 products